Heart Problems and Weight Loss: What I Tell My Heart Patients About Their Weight

When heart problems and weight loss come up in a cardiology appointment, I can usually predict the reaction: a little discomfort, maybe some defensiveness. I understand it. But when I bring it up, it has nothing to do with appearance. It has everything to do with your heart.

Excess body fat, especially the visceral fat that builds up around your abdomen, fuels inflammation, raises blood pressure, disrupts cholesterol, and forces your heart to work harder than it should. Helping my patients achieve and maintain a healthy weight is not a secondary concern in my practice. It is central to my mission as a cardiologist.

It’s Not a Willpower Problem

One of the most important things I tell my patients is this: if you’ve struggled to lose weight and keep it off, that is not a personal failure. Body weight is controlled by hormones, genetics, gut biology, stress, and sleep. It is biology. Which is exactly why I don’t just say “eat less, move more” and send people home, because I have witnessed too many patients try that approach repeatedly, with little lasting success.

What the Evidence Now Shows

The data on GLP-1 medications, semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have genuinely changed how I think about treating cardiovascular risk.

In March 2024, the FDA approved semaglutide specifically for cardiovascular risk reduction, the first weight loss medication ever recognized for its direct effect on the heart. A Lancet meta-analysis published in early 2025, drawing on over 85,000 patients across 11 trials, confirmed that GLP-1 medications reduce heart attacks, cardiovascular death, and all-cause mortality. The STEP-HFpEF trial showed meaningful benefit for heart failure patients specifically.

I believe the benefits of these medications are real and well-deserved. But I have also seen what happens when patients treat them as a quick fix, a prescription with no lifestyle support behind it. They lose weight, stop the medication, and regain it. A 2025 European Heart Journal study confirmed this clinically: stopping within a year significantly raised the risk of heart attack, stroke, and heart failure. These medications work. But they work best when paired with real, sustained habit change.

What We’ve Built at Kafri Heart & Vascular Clinic

This is precisely why I partnered with Enara Health, because I believe the best outcomes come from treating both heart problems and weight loss together, with the right team around the patient.

Through our partnership, patients have access to physicians, nutrition specialists, exercise specialists, and behavioral support, all working alongside their cardiac care, and covered by most insurance plans. In over 20 years of practicing cardiology in San Diego, I’ve seen what comprehensive, coordinated support does for patients that going it alone simply cannot.

If weight is part of your cardiac picture, that conversation shouldn’t wait. Contact Kafri Heart & Vascular Clinic to book an appointment and create your personalized plan.

For additional heart-healthy tips and overall wellness advice, check out Scripps AMG articles to stay up to date on effective practices for achieving a healthy lifestyle!

About the Author

• Source
• Update history